WSE-bound biotech company OncoArendi Therapeutics plans to raise PLN 53-66 million from the planned IPO, the company prospectus showed. It plans to issue between 0.5-2 million new shares which represent up to 14.63 percent stake in the company. On top of that, the company will offer up to 11.67 million of existing shares. The company…
Related Posts
-
PwC: IPO on the WSE and NewConnect total...
January 16, 2019 -
4Mass to debut on NewConnect on January ...
January 7, 2019 -
Movie Games plans debut before Christmas...
December 13, 2018 -
Murapol plans to debut on WSE in H2 2019...
December 12, 2018